Thanks for the tip but I'll pass on ACCP. It may be overvalued at $2.00(35M Cap)and it has very little float. If you buy its a 6-12 month hold until they actually see significant usage.
I guess I'm also cynical because they are relying on iMedicor and DMS for marketing. iMedicor claims over 740K free members, but people who are actually in the portal say its far less, and the company won't release the number. I guess ACCP assumes the big number or wouldn't have made the deal, right?
Also, ACCP is the ONLY company to agree in two years to use "ClearLobby." Does that make them visionary, or should we read into the fact that no one else believes there is value in that service?
Based on the DMS website, drug sales is not in their wheelhouse. But they have actual experienced feet on the ground it seems, and the PR suggested first phase samples were distributed to the "DMS network." DMS may be the key to ACCP success, not ClearLobby.
So, while iMedicor and DMS may be helpful, why make them the centerpiece of your marketing plan? See, too cynical to invest quite yet.
:-)